Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Current Taxes came in at $19.6 million in Q1 2026, up 77.02% YoY from $11.1 million in Q1 2025, and up 1305.87% on a QoQ basis from $1.4 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 4 years of Current Taxes data on file, last reported at $19.6 million in Q1 2026.
- Quarterly Current Taxes rose 77.02% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 77.02% YoY) and the FY2025 annual result came in at $1.4 million, up 56.15% from the prior year.
- Current Taxes grew to $19.6 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $19.6 million in Q1 2026 to a low of $15000.0 in Q2 2024.
- A 4-year average of $4.4 million and a median of $811500.0 in 2023 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes grew 22.63% — and 2025, when it surged 2826.67%.
- Tracing CPRX's Current Taxes over 4 years: stood at $729000.0 in 2023, then gained by 22.63% to $894000.0 in 2024, then soared by 56.15% to $1.4 million in 2025, then jumped by 1305.87% to $19.6 million in 2026.
- The last three Current Taxes figures came in at $19.6 million (Q1 2026), $1.4 million (Q4 2025), and $710000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 19.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.63 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 710,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 11.09 Mn |
| Dec 31, 2024 | 894,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Dec 31, 2023 | 729,000.00 |